Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Zisman

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Drugs|February 19, 2004
Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approachesMoisés Selman, Victor J Thannickal, Annie Pardo, et al.
The New England Journal of Medicine|May 21, 2010
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis, David A Zisman, Marvin Schwarz, et al.
Biochemical and Biophysical Research Communications|December 19, 2006
Circulating peripheral blood fibrocytes in human fibrotic interstitial lung diseaseBorna Mehrad, Marie D Burdick, David A Zisman, et al.
Respiratory Medicine|July 3, 2007
Prediction of pulmonary hypertension in idiopathic pulmonary fibrosisDavid A Zisman, David J Ross, John A Belperio, et al.
Mayo Clinic Proceedings|February 9, 2007
Retrospective study of pulmonary function tests in patients presenting with isolated reduction in single-breath diffusion capacity: implications for the diagnosis of combined obstructive and restrictive lung diseaseJavier F Aduen, David A Zisman, Syed I Mobin, et al.
American Journal of Respiratory and Critical Care Medicine|October 27, 2004
CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodelingMarie D Burdick, Lynne A Murray, Michael P Keane, et al.
Pulmonary Therapy|July 25, 2025
Study Design and Rationale for the PHINDER Study: Pulmonary Hypertension Screening in Patients with Interstitial Lung Disease for Earlier DetectionTejaswini Kulkarni, David A Zisman, Oksana A Shlobin, et al.
Chest|June 19, 2007
High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosisDavid A Zisman, Arun S Karlamangla, David J Ross, et al.
American Journal of Respiratory and Critical Care Medicine|December 14, 2002
Echocardiographic assessment of pulmonary hypertension in patients with advanced lung diseaseSelim M Arcasoy, Jason D Christie, Victor A Ferrari, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 1, 2009
Treprostinil to reverse pulmonary hypertension associated with idiopathic pulmonary fibrosis as a bridge to single-lung transplantationRajeev Saggar, Shelley S Shapiro, David J Ross, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Drugs|February 19, 2004
Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approachesMoisés Selman, Victor J Thannickal, Annie Pardo, et al.
The New England Journal of Medicine|May 21, 2010
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis, David A Zisman, Marvin Schwarz, et al.
Biochemical and Biophysical Research Communications|December 19, 2006
Circulating peripheral blood fibrocytes in human fibrotic interstitial lung diseaseBorna Mehrad, Marie D Burdick, David A Zisman, et al.
Respiratory Medicine|July 3, 2007
Prediction of pulmonary hypertension in idiopathic pulmonary fibrosisDavid A Zisman, David J Ross, John A Belperio, et al.
Mayo Clinic Proceedings|February 9, 2007
Retrospective study of pulmonary function tests in patients presenting with isolated reduction in single-breath diffusion capacity: implications for the diagnosis of combined obstructive and restrictive lung diseaseJavier F Aduen, David A Zisman, Syed I Mobin, et al.
American Journal of Respiratory and Critical Care Medicine|October 27, 2004
CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodelingMarie D Burdick, Lynne A Murray, Michael P Keane, et al.
Pulmonary Therapy|July 25, 2025
Study Design and Rationale for the PHINDER Study: Pulmonary Hypertension Screening in Patients with Interstitial Lung Disease for Earlier DetectionTejaswini Kulkarni, David A Zisman, Oksana A Shlobin, et al.
Chest|June 19, 2007
High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosisDavid A Zisman, Arun S Karlamangla, David J Ross, et al.
American Journal of Respiratory and Critical Care Medicine|December 14, 2002
Echocardiographic assessment of pulmonary hypertension in patients with advanced lung diseaseSelim M Arcasoy, Jason D Christie, Victor A Ferrari, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 1, 2009
Treprostinil to reverse pulmonary hypertension associated with idiopathic pulmonary fibrosis as a bridge to single-lung transplantationRajeev Saggar, Shelley S Shapiro, David J Ross, et al.
Pageof 3